UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre

Journal of antimicrobial chemotherapy, 2022-03, Vol.77 (4), p.1133-1139

2022

Volltextzugriff (PDF)

Long-term impact of COVID-19 associated acute respiratory distress syndrome

The Journal of infection, 2021-11, Vol.83 (5), p.581-588

2021

Volltextzugriff (PDF)

Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study

Journal of antimicrobial chemotherapy, 2023-08, Vol.78 (8), p.1955-1962

2023

Volltextzugriff (PDF)

Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life—Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain

AIDS and behavior, 2022-12, Vol.26 (12), p.4055-4062

2022

Volltextzugriff (PDF)

Short-term effectiveness and tolerability of carbon dioxide laser for anal high-grade squamous intraepithelial lesions in individuals living with HIV

International journal of STD & AIDS, 2022-06, Vol.33 (7), p.709-717

2022

Volltextzugriff (PDF)

Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020

Euro surveillance : bulletin européen sur les maladies transmissibles, 2023-03, Vol.28 (10), p.1

2023

Volltextzugriff (PDF)

Who is lost to follow‐up in HIV care? Assessment of care retention over time and the impact of COVID‐19. Longitudinal analysis of the PISCIS cohort

HIV medicine, 2023-09, Vol.24 (9), p.965-978

2023

Volltextzugriff (PDF)

PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement

Enfermedades infecciosas y microbiologia clinica (English ed.), 2023-01

2023

Volltextzugriff (PDF)

Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years’ Experience

Infectious diseases and therapy, 2023-02, Vol.12 (2), p.425-442

2023

Volltextzugriff (PDF)

Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study

Infectious diseases and therapy, 2023-08, Vol.12 (8), p.2179-2189

2023

Volltextzugriff (PDF)

Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study

Infectious diseases and therapy, 2022-12, Vol.11 (6), p.2111-2124

2022

Volltextzugriff (PDF)

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)

Open forum infectious diseases, 2023-08, Vol.10 (8), p.ofad374-ofad374

2023

Volltextzugriff (PDF)

Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study

Journal of antimicrobial chemotherapy, 2024-09, Vol.79 (9), p.2343-2353

2024

Volltextzugriff (PDF)

Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis

Journal of antimicrobial chemotherapy, 2024-08, Vol.79 (8), p.1775-1783

2024

Volltextzugriff (PDF)

Perception of quality of care using patient reported experience measures (PREMs) in a cohort of adults with HIV: A cross-sectional study

Medicine (Baltimore), 2023-04, Vol.102 (14), p.e33442-e33442

2023

Volltextzugriff (PDF)

Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infections

AIDS (London), 2022-05, Vol.36 (6), p.829-838

2022

Volltextzugriff (PDF)

Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations

Infectious diseases and therapy, 2024-04, Vol.13 (4), p.647-658

2024

Volltextzugriff (PDF)

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

The lancet HIV, 2021-11, Vol.8 (11), p.e701-e710

2021

Volltextzugriff (PDF)

Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands

International journal of epidemiology, 2023-08, Vol.52 (4), p.e241-e252

2023

Volltextzugriff (PDF)

Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study

Journal of antimicrobial chemotherapy, 2022-07, Vol.77 (8), p.2265-2273

2022

Volltextzugriff (PDF)

Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens

Journal of antimicrobial chemotherapy, 2023-01, Vol.78 (1), p.108-116

2023

Volltextzugriff (PDF)

Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project

HIV medicine, 2024-04, Vol.25 (4), p.424-439

2024

Volltextzugriff (PDF)

Experiencia de un programa de profilaxis preexposición en una unidad de virus de la inmunodeficiencia humana hospitalaria. Descripción del perfil basal del usuario e identificación de oportunidades de mejora

Enfermedades infecciosas y microbiología clínica, 2023-01, Vol.41 (1), p.24-28

2023

Volltextzugriff (PDF)

PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement

Enfermedades infecciosas y microbiologia clinica (English ed.), 2023-01, Vol.41 (1), p.24-28

2023

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(31)
Berichte
(1)

Sprache

Englisch
(31)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre

Long-term impact of COVID-19 associated acute respiratory distress syndrome

Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study

Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life—Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain

Short-term effectiveness and tolerability of carbon dioxide laser for anal high-grade squamous intraepithelial lesions in individuals living with HIV

Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020

Who is lost to follow‐up in HIV care? Assessment of care retention over time and the impact of COVID‐19. Longitudinal analysis of the PISCIS cohort

PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement

Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years’ Experience

Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study

Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)

Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study

Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis

Perception of quality of care using patient reported experience measures (PREMs) in a cohort of adults with HIV: A cross-sectional study

Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infections

Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

Increasing and sustaining blood-borne virus screening in Spain and Portugal throughout the COVID-19 pandemic: a multi-center quality improvement intervention

Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands

Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study

Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens

Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project

Experiencia de un programa de profilaxis preexposición en una unidad de virus de la inmunodeficiencia humana hospitalaria. Descripción del perfil basal del usuario e identificación de oportunidades de mejora

PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement

Suchergebnisse filtern